Profile

Karen Reeves is currently the SVP-Clinical Strategy & Investments at Ligand Pharmaceuticals, Inc. and the President & Chief Medical Officer at AZTherapies, Inc. Previously, she served as an Independent Director at Kiromic Biopharma, Inc. in 2022.
She also held positions at Pfizer Inc. as the VP & Head-Global Clinical Submissions Quality, Medivation LLC (California) as the Senior Vice President-Clinical Development, and Astellas Pharma, Inc. as the VP & Head-Global Medical Science.
Dr. Reeves completed her undergraduate degree at Yale University and obtained her doctorate from the University of Vermont College of Medicine.

Karen Reeves active positions

CompaniesPositionStart
LIGAND PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 19/02/2024
President 31/08/2017
All active positions of Karen Reeves

Former positions of Karen Reeves

CompaniesPositionEnd
KIROMIC BIOPHARMA, INC. Director/Board Member 05/12/2022
MEDIVATION INC Corporate Officer/Principal 28/03/2010
ASTELLAS PHARMA INC. Corporate Officer/Principal -
PFIZER, INC. Corporate Officer/Principal -
See the detail of Karen Reeves's experience

Training of Karen Reeves

Yale University Undergraduate Degree
University of Vermont College of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karen Reeves's experience

Connections

27

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
KIROMIC BIOPHARMA, INC.

Health Technology

PFIZER, INC.

Health Technology

LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

ASTELLAS PHARMA INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections